Successful salvage therapy using high-dose furmonertinib (AST2818) for non–small-cell lung cancer after Osimertinib resistance: a case report

por Cheng, Daoan, Tang, Shuxian, Li, Dong, Zhao, Weiqing, Wei, Wei, Fang, Cheng, Ji, Mei
Publicado 2022

M2-TAMs promote immunoresistance in lung adenocarcinoma by enhancing METTL3-mediated m6A methylation

por Wu, Lige, Cheng, Daoan, Yang, Xin, Zhao, Weiqing, Fang, Cheng, Chen, Rui, Ji, Mei
Publicado 2022

Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma

por Cheng, Daoan, Zhao, Weiqing, Chen, Rui, Li, Dong, Tang, Shuxian, Fang, Cheng, Ji, Mei
Publicado 2023

Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects

por Cheng, Daoan, Ge, Kele, Yao, Xue, Wang, Banglu, Chen, Rui, Zhao, Weiqing, Fang, Cheng, Ji, Mei
Publicado 2023

PD-1 blockade combined with gemcitabine plus nab-paclitaxel is superior to chemotherapy alone in the management of unresectable stage III/IV pancreatic cancer: a retrospective real...

por Cheng, Daoan, Hu, Jing, Wu, Xiaoyu, Wang, Banglu, Chen, Rui, Zhao, Weiqing, Fang, Cheng, Ji, Mei
Publicado 2023